Kwality Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	120.2	22.58	30.7	91.35	58.09
Short-Term Investments	-	27.35	36.86	42.94	38.16	44.38
Cash & Short-Term Investments	340.51	147.55	59.44	73.63	129.51	102.46
Cash Growth	338.74%	148.25%	-19.28%	-43.14%	26.40%	110.14%
Accounts Receivable	-	1,543	1,144	716.94	691.31	357.11
Other Receivables	-	127.94	163.82	68.96	88.01	-
Receivables	-	1,671	1,308	785.91	779.32	357.11
Inventory	-	834.66	783.87	863.15	533.6	307.84
Prepaid Expenses	-	-	-	-	-	0.9
Other Current Assets	-	184.57	275.9	349.31	835.76	290.69
Total Current Assets	-	2,838	2,427	2,072	2,278	1,059
Property, Plant & Equipment	-	1,440	1,391	1,348	1,039	594.21
Long-Term Investments	-	-	-	9.32	7.82	0.56
Other Intangible Assets	-	17.07	-	-	-	-
Long-Term Deferred Tax Assets	-	16.15	0.25	-	-	0.38
Other Long-Term Assets	-	161.88	124.4	107.12	81.08	8.5
Total Assets	-	4,473	3,942	3,536	3,406	1,663
Accounts Payable	-	557.93	443.17	351.92	345.15	262.15
Accrued Expenses	-	12.73	26.24	8.48	5.58	19.61
Short-Term Debt	-	973.26	785.59	629.61	337.23	164.55
Current Portion of Long-Term Debt	-	-	-	-	91.8	65.09
Current Income Taxes Payable	-	59.31	65.21	64.84	410	58
Other Current Liabilities	-	91.82	198.29	204.6	205.1	213.51
Total Current Liabilities	-	1,695	1,519	1,259	1,395	782.91
Long-Term Debt	-	151.19	195.6	273.03	202.88	182.64
Pension & Post-Retirement Benefits	-	2.52	2.16	9.03	7.53	6.78
Long-Term Deferred Tax Liabilities	-	-	-	4.11	2.75	-
Other Long-Term Liabilities	-	0	-	-	-	91.8
Total Liabilities	-	1,849	1,716	1,546	1,608	1,064
Common Stock	-	103.76	103.76	103.76	103.76	103.76
Additional Paid-In Capital	-	84.68	84.68	84.68	-	84.68
Retained Earnings	-	2,444	2,046	1,809	1,700	414.27
Comprehensive Income & Other	-	7.71	7.63	8	8.04	8.82
Total Common Equity	2,901	2,640	2,242	2,005	1,811	611.53
Minority Interest	-	-16.52	-16.28	-14.47	-13.55	-13.02
Shareholders' Equity	2,885	2,624	2,226	1,991	1,798	598.51
Total Liabilities & Equity	-	4,473	3,942	3,536	3,406	1,663
Total Debt	1,104	1,124	981.19	902.64	631.92	412.28
Net Cash (Debt)	-763.9	-976.9	-921.75	-829	-502.41	-309.82
Net Cash Per Share	-73.53	-94.15	-88.83	-79.89	-48.42	-29.86
Filing Date Shares Outstanding	10.38	10.38	10.38	10.38	10.38	10.38
Total Common Shares Outstanding	10.38	10.38	10.38	10.38	10.38	10.38
Working Capital	-	1,143	908.39	812.54	883.33	276.09
Book Value Per Share	279.50	254.48	216.08	193.25	174.58	58.94
Tangible Book Value	2,885	2,623	2,242	2,005	1,811	611.53
Tangible Book Value Per Share	277.94	252.83	216.08	193.25	174.58	58.94
Land	-	-	-	-	-	10.58
Buildings	-	577.85	519.84	281.53	228.11	214.88
Machinery	-	1,515	1,357	1,272	966.75	582.46
Construction In Progress	-	-	-	142.92	121.49	28.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.